APLP2 and neoplasm: These results suggest that there is a threshold level of APLP2 in the KPC mouse pancreas that facilitates tumor pathogenicity, and falling below that threshold to only half that level (i.e., to the heterozygous level) impairs APLP2′s ability to exercise its pro-tumor effects.